CBIZ Investment Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.91K Sell
57
-563
-91% -$65K ﹤0.01% 186
2025
Q4
$65.8K Buy
620
+71
+13% +$6.67K ﹤0.01% 118
2025
Q3
$46.5K Buy
549
+202
+58% +$16.6K ﹤0.01% 135
2025
Q2
$27.5K Sell
347
-30
-8% -$2.38K ﹤0.01% 212
2025
Q1
$34K Buy
377
+221
+142% +$20.6K ﹤0.01% 149
2024
Q4
$15.5K Sell
156
-66
-30% -$6.8K ﹤0.01% 245
2024
Q3
$25.5K Buy
222
+61
+38% +$7.25K ﹤0.01% 156
2024
Q2
$20K Sell
161
-100
-38% -$12.9K ﹤0.01% 167
2024
Q1
$34.5K Buy
+261
New +$32.2K ﹤0.01% 117
2021
Q3
Hold
0
82
2021
Q2
Hold
0
84
2020
Q4
Hold
0
86
2020
Q3
Hold
0
83
2020
Q2
Hold
0
94
2020
Q1
Hold
0
81
2019
Q4
Hold
0
117

Other funds holding MRK

CBIZ Investment Advisory Services's MRK Position: Q1 2026 in Review

CBIZ Investment Advisory Services reduced its Merck (MRK) stake by 91% in Q1 2026, selling an estimated $65K and leaving 57 shares worth $6.91K. The position accounts for ﹤0.01% of the portfolio, ranked #186.

CBIZ Investment Advisory Services first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $65.8K in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • CBIZ Investment Advisory Services held 57 shares of Merck worth $6.91K as of Q1 2026.
  • CBIZ Investment Advisory Services sold 563 Merck shares in Q1 2026, an estimated $65K.
  • Merck made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q1 2026, its #186 holding.
  • CBIZ Investment Advisory Services first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • CBIZ Investment Advisory Services's Merck position peaked at $65.8K in Q4 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.